ANDREEA NAGY: Open Payments
NPI 1376171496 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 33 payments from 13 companies in 2025. Trend: 2023 $436 · 2024 $625 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $220 |
| Novo Nordisk Inc | 10 | $149 |
| Amgen Inc. | 3 | $53 |
| Exact Sciences Corporation | 1 | $34 |
| Boston Scientific Corporation | 1 | $29 |
| Globus Medical, Inc. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Lilly USA, LLC | 1 | $25 |
| Eisai Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: UBRELVY, QULIPTA, Rybelsus, Ozempic, EVENITY, Cologuard Collection Kit, WATCHMAN FLX, Senza.
Industry payments across FL — which companies pay providers there.
